Cancer BiologybioRxiv
Multiple Low Dose therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
J. M. Fernandes Neto, E. Nadal, S. N. Ooft…·R. Bernards
This paper shows that using multiple low doses of drugs targeting different components of a signaling pathway can effectively treat EGFR inhibitor-resistant NSCLC without resistance development.
DOI 10.1038/s41467-020-16952-9